Portola Pharma Q4 Loss Widens - Quick Facts

(RTTNews) - Portola Pharmaceuticals Inc. (PTLA) Thursday reported fourth-quarter net loss of $25.06 million or $0.63 per share, wider than $13.78 million or $10.02 per share last year.

Results for the latest quarter were calculated on 39.47 million outstanding shares, compared to 1.37 million outstanding shares in the year-ago quarter.

Collaboration and license revenues for the quarter edged up $2.06 million from $1.96 million in the same quarter last year.

Analysts polled by Thomson Reuters estimated a loss of $0.57 per share on annual revenues of $2.17 million for the quarter. Analysts' estimates typically exclude special items.